Clinical Trial Update: Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial update for ARC-IM Therapy to alleviate locomotor deficits in Parkinson's disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ARC-IM Therapy

Snippet

Sponsor: Ecole Polytechnique Fédérale de Lausanne | Conditions: Parkinson Disease | NA | Status: RECRUITING